KEMRI/Wellcome Trust Research Programme, Kilifi, Kenya.
The Childhood Acute Illness and Nutrition Network (CHAIN), Nairobi, Kenya.
Matern Child Nutr. 2018 Apr;14(2):e12569. doi: 10.1111/mcn.12569. Epub 2017 Nov 27.
The effects of rickets on children recovery from severe acute malnutrition (SAM) are unknown. Rickets may affect both growth and susceptibility to infectious diseases. We investigated the associations of clinically diagnosed rickets with life-threatening events and anthropometric recovery during 1 year following inpatient treatment for complicated SAM. This was a secondary analysis of clinical trial data among non-human immunodeficiency virus-infected Kenyan children with complicated SAM (2-59 months) followed for 1 year posthospital discharge (ClinicalTrials.gov ID NCT00934492). The outcomes were mortality, hospital readmissions, and growth during 12 months. The main exposure was clinically diagnosed rickets at baseline. Of 1,778 children recruited, 230 (12.9%, 95% CI [11.4, 14 .6]) had clinical signs of rickets at baseline. Enrolment at an urban site, height-for-age and head circumference-for-age z scores were associated with rickets. Rickets at study enrolment was associated with increased mortality (adjusted Hazard Ratio [aHR] 1.61, 95% CI [1.14, 2.27]), any readmission (aHR 1.37, 95% CI [1.09, 1.72]), readmission for severe pneumonia (aHR 1.37, 95% CI [1.05, 1.79]), but not readmission with diarrhoea (aHR 1.05, 95% CI [0.73, 1.51]). Rickets was associated with increased height gain (centimetres), adjusted regression coefficient 0.19 (95% CI [0.10, 0.28]), but not changes in head circumference, mid-upper arm circumference, or weight. Rickets was common among children with SAM at urban sites and associated with increased risks of severe pneumonia and death. Increased height gain may have resulted from vitamin D and calcium treatment. Future work should explore possibility of other concurrent micronutrient deficiencies and optimal treatment of rickets in this high-risk population.
佝偻病对严重急性营养不良(SAM)患儿康复的影响尚不清楚。佝偻病可能会影响生长和对传染病的易感性。我们研究了在因复杂 SAM 住院治疗后 1 年内,临床诊断为佝偻病与危及生命的事件和人体测量学恢复之间的关系。这是对肯尼亚非人类免疫缺陷病毒感染的复杂 SAM(2-59 个月)患儿进行的临床试验数据的二次分析,这些患儿在出院后 1 年内进行了随访(ClinicalTrials.gov 标识符 NCT00934492)。结果是 12 个月时的死亡率、住院再入院率和生长情况。主要暴露因素是基线时临床诊断的佝偻病。在纳入的 1778 名儿童中,230 名(12.9%,95%CI [11.4, 14.6])在基线时存在佝偻病的临床体征。在城市地点入组、身高年龄和头围年龄 z 评分与佝偻病有关。研究入组时的佝偻病与死亡率增加有关(校正后的危害比 [aHR] 1.61,95%CI [1.14, 2.27])、任何再入院(aHR 1.37,95%CI [1.09, 1.72])、因严重肺炎再入院(aHR 1.37,95%CI [1.05, 1.79]),但因腹泻再入院(aHR 1.05,95%CI [0.73, 1.51])的风险没有增加。佝偻病与身高增长(厘米)有关,调整后的回归系数为 0.19(95%CI [0.10, 0.28]),但与头围、中上臂围或体重的变化无关。佝偻病在城市地区的 SAM 儿童中很常见,与严重肺炎和死亡风险增加有关。身高增长增加可能是由于维生素 D 和钙的治疗。未来的工作应该探索在这一高危人群中佝偻病与其他并发微量营养素缺乏症的可能性以及佝偻病的最佳治疗方法。